- Home
- CERT vs ALVO Comparison
CERT vs ALVO Comparison
Compare CERT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CERT | ALVO |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CERT | ALVO |
|---|---|---|
| Price | $7.29 | $5.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $12.78 | $9.25 |
| AVG Volume (30 Days) | ★ 2.2M | 311.2K |
| Earning Date | 02-26-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.07 | ★ 0.24 |
| Revenue | $415,551,000.00 | ★ $573,350,000.00 |
| Revenue This Year | $10.75 | $20.85 |
| Revenue Next Year | $6.32 | $44.49 |
| P/E Ratio | $109.10 | ★ $20.78 |
| Revenue Growth | 11.47 | ★ 45.55 |
| 52 Week Low | $7.30 | $4.32 |
| 52 Week High | $15.69 | $13.08 |
Technical Indicators
Market Signals| Indicator | CERT | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 24.85 | 49.39 |
| Support Level | $7.49 | $4.95 |
| Resistance Level | $10.21 | $5.45 |
| Average True Range (ATR) | 0.44 | 0.22 |
| MACD | -0.27 | -0.00 |
| Stochastic Oscillator | 2.38 | 45.78 |
Price Performance
Historical ComparisonAbout CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.